FUNDAMENTALS · Fundamentals · KR Technology

ICD (040910) Fundamentals 2026 — P/E 76.1x, Revenue Analysis | SniperIQ

ICD (040910) is a KR-listed Technology company in Hardware, Equipment & Parts with a market capitalization of ₩66.3B, trading at ₩4060.00 on the KOE. This SniperIQ fundamentals page covers ICD's valuation (P/E 76.1x, P/B 0.7x), profitability (net margin 0.7%), revenue (₩197.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap₩66.3B
P/E (TTM)76.1x
Net Margin0.7%
Revenue (FY25)₩197.0B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is ICD's market cap?

ICD (040910) has a market capitalization of approximately ₩66.3B, trading at ₩4060.00 on the KOE. Market cap moves with the live share price.

What is ICD's P/E ratio?

ICD's trailing twelve-month P/E ratio is 76.1x, with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Technology sector peers rather than read in isolation.

How profitable is ICD?

ICD runs a net profit margin of 0.7%, a gross margin of 16.6%, and an operating margin of 3.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does ICD generate?

ICD reported revenue of ₩197.0B for fiscal year 2025, with net income of -₩1.9B and earnings per share (EPS) of -105.02. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does ICD pay a dividend?

ICD does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is ICD financially healthy?

ICD carries a debt-to-equity ratio of 0.20x and a current ratio of 1.43x, with a market beta of 0.76. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is ICD a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For ICD (040910) the key facts are: market cap ₩66.3B, P/E 76.1x, revenue ₩197.0B, 52-week range 3625-6960. Weigh valuation, profitability, growth, and balance-sheet strength against Technology peers and form your own view.

Track ICD's full fundamentals live

Get ICD's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Elite Advanced Laser (3450) fundamentals · Chang Wah Technology (6548) fundamentals · Motorola Solutions (MSI) fundamentals · SIIX (7613) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons